Carregando...
Cell death in response to antimetabolites directed at ribonucleotide reductase and thymidylate synthase
New agent development, mechanistic understanding, and combinatorial partnerships with known and novel modalities continue to be important in the study of pancreatic cancer and its improved treatment. In this study, known antimetabolite drugs such as gemcitabine (ribonucleotide reductase inhibitor) a...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Principais autores: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354452/ https://ncbi.nlm.nih.gov/pubmed/25767396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S79647 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|